We are committed to enhancing public health practices and improving health systems across African countries by leveraging antimicrobial resistance (AMR) data. Our goal is to utilize data from African nations, sourced from the ATLAS and DREAM datasets from Vivli, and GLASS from WHO, to develop continent-wide machine learning models. AI technologies will be pivotal in supporting antimicrobial stewardship by analyzing extensive AMR datasets to identify patterns, trends, and risk factors associated with antibiotic resistance. This includes detecting emerging resistance patterns and predicting future trends to develop targeted interventions and policies aimed at optimizing antibiotic prescribing practices and reducing the spread of resistant pathogens. Integrating diverse data sources, such as clinical data, surveillance data, and genotype data, will enable AI algorithms to provide real-time insights into AMR dynamics. Public health officials can use these insights to implement timely interventions, allocate resources efficiently, and design targeted awareness campaigns. Furthermore, AI contributes to strengthening health systems by optimizing resource allocation and identifying areas for improvement in antibiotic usage, infection control protocols, and healthcare infrastructure. By comprehensively analyzing AMR data, including resistance rates, treatment outcomes, and healthcare facility utilization, AI algorithms can inform evidence-based policy decisions and system-level interventions. Ultimately, integrating AI techniques with AMR data analysis has the potential to drive effective interventions and support global efforts to combat antimicrobial resistance.